Holders — by stockHoldings — by fund
Gagnon Advisors, LLC
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-09-30 · filed with the SEC up to 45 days after quarter end · CIK 0001599466
$182.1M
disclosed book value
24
positions
10.2%
largest position share
Positions, as of 2026-09-30
top 24 of 24 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | CDNACAREDX INC | 286,889 | $18.6M | 10.2% |
| 2 | EPDENTERPRISE PRODS PARTNERS L P | 339,877 | $12.1M | 6.6% |
| 3 | WGSGENEDX HOLDINGS CORP | 163,024 | $11.8M | 6.5% |
| 4 | FIVNFIVE9 INC | 336,277 | $11.4M | 6.3% |
| 5 | HNGEHINGE HEALTH INC | 113,304 | $11.0M | 6.1% |
| 6 | EQIXEQUINIX INC | 10,715 | $10.8M | 6% |
| 7 | BLFSBIOLIFE SOLUTIONS INC | 274,217 | $10.7M | 5.9% |
| 8 | FRSHFRESHWORKS INC | 776,212 | $9.9M | 5.5% |
| 9 | AMRCAMERESCO INC | 472,798 | $9.8M | 5.4% |
| 10 | PCRXPACIRA BIOSCIENCES INC | 352,637 | $8.8M | 4.9% |
| 11 | AMPLAMPLITUDE INC | 634,987 | $8.8M | 4.8% |
| 12 | NVGSNAVIGATOR HLDGS LTD | 328,488 | $7.6M | 4.2% |
| 13 | BLBLACKLINE INC | 257,915 | $6.8M | 3.8% |
| 14 | TMCITREACE MED CONCEPTS INC | 1.5M | $6.8M | 3.7% |
| 15 | DVDOUBLEVERIFY HLDGS INC | 438,039 | $5.9M | 3.2% |
| 16 | PROFPROFOUND MED CORP | 962,186 | $5.6M | 3.1% |
| 17 | OSUROraSure Technologies Inc | 1.3M | $5.0M | 2.8% |
| 18 | QDELQUIDELORTHO CORP | 432,186 | $4.6M | 2.5% |
| 19 | VERXVERTEX INC | 361,621 | $4.3M | 2.3% |
| 20 | BKDBROOKDALE SR LIVING INC | 368,349 | $4.0M | 2.2% |
| 21 | BVBRIGHTVIEW HLDGS INC | 386,513 | $3.9M | 2.1% |
| 22 | KLTRKALTURA INC | 2.5M | $3.2M | 1.7% |
| 23 | CNFCNFINANCE HLDGS LTD | 242,039 | $471,976 | 0.3% |
| 24 | BYNDBEYOND MEAT INC | 12,962 | $107,066 | 0.1% |
Source: SEC Form 13F-HR, reporting period 2026-09-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.